Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction

British Medical Journal (Clinical research ed.)

Volumn 293, Issue 6552, 1986, Pages 917-922

  Smith, C C ^a   Yudkin, J S ^a   Betteridge, D J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; GLYCOSYLATED HEMOGLOBIN; HYDROCORTISONE; NORADRENALIN;

AGE; DIAGNOSIS; ENDOCRINE SYSTEM; HEART; HEART INFARCTION; HEART INFARCTION SIZE; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STRESS;

AGED; BLOOD GLUCOSE; EPINEPHRINE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROCORTISONE; HYPERGLYCEMIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NOREPINEPHRINE; PROGNOSIS;

EID: 0022533748     PISSN: 02670623     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.293.6552.917     Document Type: Article

References (31)

1. Gwilt DJ. Why do diabetics die after myocardial infarction? Practical Diabetes 1984;1(2):36-9.
2. Husband DJ, Alberti K., Julian DG. Methods for the control of diabetes after acute myocardial infarction. Diabetes Care 1985;8:261-7.
3. Oswald G, Corcoran S, Yudkin JS. Prevalence and risks of hyperglycaemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet 1984;i:1264–7.
4. Shapiro LM, Howat AP, Calter MM. Left ventricular function in diabetes mellitus. 1-Methodology, and prevalence and spectrum of abnormalities. Br Heart J 1981;45:122-8.
5. McMillan DE. The effect of diabetes on blood flow properties. Diabetes 1983;32(suppl 2): 56–63.
6. World Health Organisation. Regional Office for Europe. Public health in Europe 5. Annex 1. Copenhagen: World Health Organisation, 1976. (Myocardial infarction community registers.)
7. Oswald GA, Yudkin JS. The relative contribution of undiagnosed diabetes mellitus and “stress” to hyperglycaemia following acute myocardial infarction. Diabetic Medicine (in press).
8. Mortensen HB. Quantitative determination of hemoglobin Alc by thin layer iso-electric focusing. J Chromatogr 1980;182:325-33.
9. Witteveen SAGJ, Hemker HC, Hollaar L, Hermens WT. Quantitation of infarct size in man by means of plasma enzyme levels. Br Heart J 1975;37:795-803.
10. Thompson PL, Fletcher EE, Katavatis V. Enzymatic indices of myocardial necrosis: influence on short and long term prognosis after myocardial infarction. Circulation 1979;59:113-9.
11. Sobel BE, Shell WE. Serum enzyme determinations in the diagnosis and assessment of myocardial infarction. Circulation 1972;45:471-82.
12. Boyle DMC, Barber JM, McIlmoyle EL, Effect of very early intervention with metoprolol on myocardial infarct size. Br Heart J 1983;49:229-33.
13. Smith CCT, Curtis LD, Delamothe AP, Prixchard BNC, Betteridge DJ. The distribution of catecholamines between platelets and plasma in normal human subjects. Clin Sci 1985;69:1-6.
14. Longstreth WT, Diehr P, Inui TS. Prediction of awakening after out-of-hospital cardiac arrest. N Engl J Med 1983;308:1378-82.
15. Silverberg AB, Shah SD, Haymond MW, Cryer PE. Norepinephrine: hormone and neurotransmitter in man. Am J Physiol 1978;234:E252-6.
16. Staszewska-Barczak J. The reflex stimulation of catecholamine secretion during the acute stage of myocardial infarction in the dog. Clin Sci 1971;41:419-39.
17. Cohn JN, Levine TB, Olivari MT, Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-23.
18. Thomas JA, Marks BH. Plasma nor-epinephrine in congestive heart failure. Am J Cardiol 1978;41:233-43.
19. Karlsberg RP, Cryer PE, Roberts R. Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: relationship to infarct extent and mortality. Am Heart J 1981;102:24-9.
20. Videbak J, Christensen NJ, Sterndoff B. Serial determination of plasma catecholamines in myocardial infarction. Circulation 1972;46:846-55.
21. Benedict CR, Grahame-Smith DG. Plasma adrenaline and noradrenaline concentrations and dopamine-β-hydroxylase activity in myocardial infarction with and without cardiogenic shock. Br Heart J 1979;42:214-20.
22. Jewitt DE, Mercer CJ, Reid D, Valori C, Thomas M, Shillingford JP. Free noradrenaline and adrenaline excretion in relation to the development of cardiac arrhythmias and heart failure in patients with acute myocardial infarction. Lancet 1969;i:635-41.
23. Bailey RR, Abernathy MH, Beaven DW. Adrenocortical response to the stress of an acute myocardial infarction. Lancet 1967;i:970-3.
24. Prakash R, Parmley WW, Horvat M, Swan HJC. Serum cortisol, plasma free fatty acids, and urinary catecholamines as indicators of complications in acute myocardial infarction. Circulation 1972;45:736-45.
25. Burckhardt P, Felber J-P, Perret C. Adrenocortical, insulin and metabolic changes in response to acute myocardial infarction. Helvetica Medica Acta 1972;36:277-93.
26. Little RA, Frayn KN, Randall PE, Plasma catecholamines in patients with acute myocardial infarction and in cardiac arrest. Q J Med 1985;54:133-40.
27. Christensen NJ, Videbak J. Plasma catecholamines and carbohydrate metabolism in patients with acute myocardial infarction. J Clin Invest 1974;54:278-86.
28. Eigler N, Sacca L, Sherwin RL. Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog. A model for stress-induced hyperglycemia. J Clin Invest 1979;63:114-23.
29. Willerson JT, Hutcheson DR, Leshin SJ, Faloona GR, Unger RH. Serum glucagon and insulin levels and their relationship to blood glucose values in patients with acute myocardial infarction and acute coronary insufficiency. Am J Med 1974;57:747-53.
30. Gwilt DJ, Petri M, Lamb P, Nattrass M, Pentecost BL. Effect of intravenous insulin infusion on mortality among diabetic patients after myocardial infarction. Br Heart J 1984;51:626-31.
31. Clark RS, English M, McNeill GP, Newton RW. Effect of intravenous infusion of insulin in diabetics with acute myocardial infarction. Br Med J 1985;291:303-5.